These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12507705)

  • 1. Powerful antinociceptive effects of the cone snail venom-derived subtype-selective NMDA receptor antagonists conantokins G and T.
    Malmberg AB; Gilbert H; McCabe RT; Basbaum AI
    Pain; 2003 Jan; 101(1-2):109-16. PubMed ID: 12507705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NR2B-selective conantokin peptide inhibitors of the NMDA receptor display enhanced antinociceptive properties compared to non-selective conantokins.
    Xiao C; Huang Y; Dong M; Hu J; Hou S; Castellino FJ; Prorok M; Dai Q
    Neuropeptides; 2008; 42(5-6):601-9. PubMed ID: 18992939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic conantokin peptides potently inhibit N-methyl-D-aspartate receptor-mediated currents of retinal ganglion cells.
    Huang L; Balsara RD; Castellino FJ
    J Neurosci Res; 2014 Dec; 92(12):1767-74. PubMed ID: 25043917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conantokins: peptide antagonists of NMDA receptors.
    Layer RT; Wagstaff JD; White HS
    Curr Med Chem; 2004 Dec; 11(23):3073-84. PubMed ID: 15579001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific determinants of conantokins that dictate their selectivity for the NR2B subunit of N-methyl-D-aspartate receptors.
    Sheng Z; Prorok M; Castellino FJ
    Neuroscience; 2010 Oct; 170(3):703-10. PubMed ID: 20688135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociceptive effect of Brazilian armed spider venom toxin Tx3-3 in animal models of neuropathic pain.
    Dalmolin GD; Silva CR; Rigo FK; Gomes GM; do Nascimento Cordeiro M; Richardson M; Silva MAR; Prado MAM; Gomez MV; Ferreira J
    Pain; 2011 Oct; 152(10):2224-2232. PubMed ID: 21570770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conantokins and variants derived from cone snail venom inhibit naloxone-induced withdrawal jumping in morphine-dependent mice.
    Wei J; Dong M; Xiao C; Jiang F; Castellino FJ; Prorok M; Dai Q
    Neurosci Lett; 2006 Sep; 405(1-2):137-41. PubMed ID: 16859831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of NMDA-induced currents by conantokin-G and conantokin-T in cultured embryonic murine hippocampal neurons.
    Klein RC; Galdzicki Z; Castellino FJ
    Neuropharmacology; 1999 Dec; 38(12):1819-29. PubMed ID: 10608277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracisternal administration of NR2 antagonists attenuates facial formalin-induced nociceptive behavior in rats.
    Yang GY; Woo YW; Park MK; Bae YC; Ahn DK; Bonfa E
    J Orofac Pain; 2010; 24(2):203-11. PubMed ID: 20401359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonist properties of Conus parius peptides on N-methyl-D-aspartate receptors and their effects on CREB signaling.
    Kunda S; Cheriyan J; Hur M; Balsara RD; Castellino FJ
    PLoS One; 2013; 8(11):e81405. PubMed ID: 24260577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-antipyrine-3, 4-dichloromaleimide, an effective cyclic imide for the treatment of chronic pain: the role of the glutamatergic system.
    Quintão NL; da Silva GF; Antonialli CS; de Campos-Buzzi F; Corrêa R; Filho VC
    Anesth Analg; 2010 Mar; 110(3):942-50. PubMed ID: 20185671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel conantokins from Conus parius venom are specific antagonists of N-methyl-D-aspartate receptors.
    Teichert RW; Jimenez EC; Twede V; Watkins M; Hollmann M; Bulaj G; Olivera BM
    J Biol Chem; 2007 Dec; 282(51):36905-13. PubMed ID: 17962189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stapling mimics noncovalent interactions of γ-carboxyglutamates in conantokins, peptidic antagonists of N-methyl-D-aspartic acid receptors.
    Platt RJ; Han TS; Green BR; Smith MD; Skalicky J; Gruszczynski P; White HS; Olivera B; Bulaj G; Gajewiak J
    J Biol Chem; 2012 Jun; 287(24):20727-36. PubMed ID: 22518838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo characterization of conantokin-R, a selective NMDA receptor antagonist isolated from the venom of the fish-hunting snail Conus radiatus.
    White HS; McCabe RT; Armstrong H; Donevan SD; Cruz LJ; Abogadie FC; Torres J; Rivier JE; Paarmann I; Hollmann M; Olivera BM
    J Pharmacol Exp Ther; 2000 Jan; 292(1):425-32. PubMed ID: 10604979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conantokins derived from the Asprella clade impart conRl-B, an N-methyl d-aspartate receptor antagonist with a unique selectivity profile for NR2B subunits.
    Gowd KH; Han TS; Twede V; Gajewiak J; Smith MD; Watkins M; Platt RJ; Toledo G; White HS; Olivera BM; Bulaj G
    Biochemistry; 2012 Jun; 51(23):4685-92. PubMed ID: 22594498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conantokin G is an NR2B-selective competitive antagonist of N-methyl-D-aspartate receptors.
    Donevan SD; McCabe RT
    Mol Pharmacol; 2000 Sep; 58(3):614-23. PubMed ID: 10953056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The amino acid residue at sequence position 5 in the conantokin peptides partially governs subunit-selective antagonism of recombinant N-methyl-D-aspartate receptors.
    Klein RC; Prorok M; Galdzicki Z; Castellino FJ
    J Biol Chem; 2001 Jul; 276(29):26860-7. PubMed ID: 11335724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn.
    Boyce S; Wyatt A; Webb JK; O'Donnell R; Mason G; Rigby M; Sirinathsinghji D; Hill RG; Rupniak NM
    Neuropharmacology; 1999 May; 38(5):611-23. PubMed ID: 10340299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point mutations identify the glutamate binding pocket of the N-methyl-D-aspartate receptor as major site of conantokin-G inhibition.
    Wittekindt B; Malany S; Schemm R; Otvos L; Maccecchini ML; Laube B; Betz H
    Neuropharmacology; 2001 Nov; 41(6):753-61. PubMed ID: 11640930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity studies of conantokins as human N-methyl-D-aspartate receptor modulators.
    Nielsen KJ; Skjaerbaek N; Dooley M; Adams DA; Mortensen M; Dodd PR; Craik DJ; Alewood PF; Lewis RJ
    J Med Chem; 1999 Feb; 42(3):415-26. PubMed ID: 9986713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.